Mechanobiology and Primary Cilium in the Pathophysiology of Bone Marrow Myeloproliferative Diseases
- PMID: 39201546
- PMCID: PMC11354938
- DOI: 10.3390/ijms25168860
Mechanobiology and Primary Cilium in the Pathophysiology of Bone Marrow Myeloproliferative Diseases
Abstract
Philadelphia-Negative Myeloproliferative neoplasms (MPNs) are a diverse group of blood cancers leading to excessive production of mature blood cells. These chronic diseases, including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), can significantly impact patient quality of life and are still incurable in the vast majority of the cases. This review examines the mechanobiology within a bone marrow niche, emphasizing the role of mechanical cues and the primary cilium in the pathophysiology of MPNs. It discusses the influence of extracellular matrix components, cell-cell and cell-matrix interactions, and mechanosensitive structures on hematopoietic stem cell (HSC) behavior and disease progression. Additionally, the potential implications of the primary cilium as a chemo- and mechanosensory organelle in bone marrow cells are explored, highlighting its involvement in signaling pathways crucial for hematopoietic regulation. This review proposes future research directions to better understand the dysregulated bone marrow niche in MPNs and to identify novel therapeutic targets.
Keywords: bone marrow niche; hematopoietic stem cells; mechanobiology; mesenchymal stromal cells; myeloproliferative neoplasms; primary cilium.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.Ann Hematol. 2021 Jan;100(1):105-116. doi: 10.1007/s00277-020-04306-w. Epub 2020 Oct 21. Ann Hematol. 2021. PMID: 33089365
-
Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis.Adv Exp Med Biol. 2023;1408:273-290. doi: 10.1007/978-3-031-26163-3_15. Adv Exp Med Biol. 2023. PMID: 37093433
-
Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.Leuk Lymphoma. 2019 Apr;60(4):876-885. doi: 10.1080/10428194.2018.1516881. Epub 2018 Oct 2. Leuk Lymphoma. 2019. PMID: 30277128 Review.
-
The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.Am J Hematol. 2013 May;88(5):355-8. doi: 10.1002/ajh.23409. Epub 2013 Mar 12. Am J Hematol. 2013. PMID: 23494965
-
Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.Cancer Treat Res. 2019;179:159-178. doi: 10.1007/978-3-030-20315-3_11. Cancer Treat Res. 2019. PMID: 31317487 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources